NovaXS Biotech has developed Telosis, a patent-pending needle-free drug delivery system that enables patients to self-administer medications subcutaneously or intramuscularly while tracking their treatment through a dedicated app. This technology addresses the challenges of needle phobia and medication adherence, improving patient compliance and treatment outcomes for chronic conditions.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many patients experience anxiety and adherence issues related to traditional subcutaneous and intramuscular injections using needles, especially for chronic conditions requiring frequent self-administration. The lack of detailed injection data also hinders effective treatment monitoring and optimization.
Solution
NovaXS Biotech offers Telosis, a needle-free drug delivery system designed for subcutaneous or intramuscular self-administration. The system replaces needles with a virtually painless injection method, reducing patient anxiety and improving compliance. A companion mobile app tracks injection data, providing patients with reminders and dosage information, while also supplying clinicians with detailed treatment records to optimize therapy and improve patient outcomes.
Target Audience
The primary target audience includes patients requiring frequent subcutaneous or intramuscular injections, particularly those undergoing fertility treatments or managing chronic conditions like diabetes and arthritis, as well as biotechnology companies developing DNA therapies.
Features
- Needle-free injection technology for subcutaneous and intramuscular drug delivery
- Smart injection reminder system via a dedicated mobile application
- Injection tracking system to monitor dosage and timing
- Integration with a mobile app to record and display injection history
- User-friendly interface designed to reduce anxiety associated with self-injection
- Capability to deliver various medications for fertility treatments, chronic diseases, and DNA therapies